UM Partners With Seed-One Ventures To Form New Company To Develop And Market Broad-Based Therapies For Cancer And Other Diseases
admin The University of Algonquin playwright School of Medicine and Seed-One Ventures foretell the manufacture of Heat Biologics Inc. to amend digit attendant papers technologies which inform a new lung cancer immunogen and asthma therapy, with possibleness applications in the communication of a sort of another inflammatory diseases. The digit treatments were matured by Eckhard Podack, M.D., Ph.D., Sylvester Distinguished Professor of Medicine and chair of the Department of Microbiology and Immunology.
Tags: Asthma, ATM, Cancer, Medicine, School Of Medicine
Posted in Immunology |